ADVFN Logo ADVFN

We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now

Toplists

It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Sign Up

Already a member? Sign in

Options Flow

Live Options Flow

Market Data
News
Trading Tools
Markets
Discover

Hot Features

Follow Feed

Connect with traders and investors in our Follow Feed community.

Options Flow

Explore comprehensive options data and use advanced filters with Options Flow.

Monitor

Organize and monitor your stock and asset watchlist with Monitor.
Sign In Premium IconPremium Help Menu
S&P TSX Capped Composite...
34.54
-0.09%
US Tech 100
19,220.00
-0.20%
S&P 500
5,464.62
-0.16%
US Dollar vs CAD
1.36995
0.00%
Bitcoin
64,102.34
-0.22%
Registration Strip Icon for tools Level up your trading with our powerful tools and real-time insights all in one place.
Get Started
  1. Home
  2. Investing
  3. Stocks
  4. USA
  5. NASDAQ
  6. Standard BioTools Inc (LAB)

  7. Standard BioTools Inc (LAB) News

LAB

Standard BioTools (LAB)

Standard BioTools Inc
Date:
Sort by:
 Showing the most relevant articles for your search:NASDAQ:LAB
DateTimeSourceHeadlineSymbolCompany
06/03/20244:20PMEdgar (US Regulatory)Form SC 13D/A - General statement of acquisition of beneficial ownership: [Amend]NASDAQ:LABStandard BioTools Inc
06/03/20244:19PMEdgar (US Regulatory)Form DEFA14A - Additional definitive proxy soliciting materials and Rule 14(a)(12) materialNASDAQ:LABStandard BioTools Inc
06/03/20245:05AMEdgar (US Regulatory)Form 8-K - Current reportNASDAQ:LABStandard BioTools Inc
05/29/20243:34PMEdgar (US Regulatory)Form SD - Specialized disclosure reportNASDAQ:LABStandard BioTools Inc
05/28/20247:45PMEdgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:LABStandard BioTools Inc
05/28/20243:01PMGlobeNewswire Inc.Standard BioTools Purchases the Carterra® LSA-XT System to Accelerate Data Delivery and Provide Greater Validation to SomaScan CustomersNASDAQ:LABStandard BioTools Inc
05/22/20246:53PMEdgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:LABStandard BioTools Inc
05/22/20243:54PMEdgar (US Regulatory)Form SC 13D/A - General statement of acquisition of beneficial ownership: [Amend]NASDAQ:LABStandard BioTools Inc
05/22/20243:01PMGlobeNewswire Inc.Standard BioTools to Participate in Upcoming Investor ConferencesNASDAQ:LABStandard BioTools Inc
05/21/20244:37PMEdgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:LABStandard BioTools Inc
05/21/20244:35PMEdgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:LABStandard BioTools Inc
05/21/20244:34PMEdgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:LABStandard BioTools Inc
05/21/20244:16PMEdgar (US Regulatory)Form ARS - Annual Report to Security HoldersNASDAQ:LABStandard BioTools Inc
05/21/20244:15PMEdgar (US Regulatory)Form DEFC14A - Definitive proxy statement, contested solicitationsNASDAQ:LABStandard BioTools Inc
05/20/20247:00AMGlobeNewswire Inc.Standard BioTools Inc. Announces Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)NASDAQ:LABStandard BioTools Inc
05/20/20245:03AMEdgar (US Regulatory)Form PRER14A - Preliminary Proxy Soliciting materialsNASDAQ:LABStandard BioTools Inc
05/17/20247:11PMEdgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:LABStandard BioTools Inc
05/16/20248:07PMEdgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:LABStandard BioTools Inc
05/10/20244:16PMEdgar (US Regulatory)Form PREC14A - Preliminary proxy statements, contested solicitationsNASDAQ:LABStandard BioTools Inc
05/09/20243:53PMEdgar (US Regulatory)Form 10-Q - Quarterly report [Sections 13 or 15(d)]NASDAQ:LABStandard BioTools Inc
05/08/20243:31PMEdgar (US Regulatory)Form 8-K - Current reportNASDAQ:LABStandard BioTools Inc
05/08/20243:01PMGlobeNewswire Inc.Standard BioTools Reports First Quarter 2024 Financial ResultsNASDAQ:LABStandard BioTools Inc
04/25/20247:01AMGlobeNewswire Inc.Standard BioTools Announces Operational Restructuring Plan to Drive Long-Term Profitable GrowthNASDAQ:LABStandard BioTools Inc
04/25/20247:00AMGlobeNewswire Inc.Standard BioTools Announces Conference Call and Webcast for First Quarter 2024 Financial Results on May 8, 2024NASDAQ:LABStandard BioTools Inc
04/08/20247:00AMGlobeNewswire Inc.Standard BioTools Introduces New High-Throughput Multiplexed Whole Slide Imaging Modalities Set to Redefine the boundaries of Tissue ImagingNASDAQ:LABStandard BioTools Inc
04/03/20243:01PMGlobeNewswire Inc.Standard BioTools Announces Multi-Year Strategic Engagement with Bristol Myers Squibb for Use of the SomaScan® Platform for Translational Medicine ResearchNASDAQ:LABStandard BioTools Inc
03/18/20247:12AMGlobeNewswire Inc.Standard BioTools Announces Exchange of All Outstanding Series B Convertible Preferred Stock for Common StockNASDAQ:LABStandard BioTools Inc
03/06/20246:20PMEdgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:LABStandard BioTools Inc
02/28/20243:05PMEdgar (US Regulatory)Form 8-K - Current reportNASDAQ:LABStandard BioTools Inc
02/28/20243:01PMGlobeNewswire Inc.Standard BioTools Reports Fourth Quarter and Full Year 2023 Financial ResultsNASDAQ:LABStandard BioTools Inc
 Showing the most relevant articles for your search:NASDAQ:LAB

Your Recent History

NASDAQ
RVLT
Revolution Lighting Tech...
NYSE
NPTN
NeoPhotonics
LSE
49RD
Lloyds Bk.44
EU
DBRAP
Departement Bouches du R...
Delayed Upgrade Clock
ADVFN Logo
InvestorsHub

Canada
Company
Business
Popular
Get The App
App Store
Google Play

Support: +44 (0) 203 8794 460 | support@advfn.com

By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions

© 2024 ADVFN PLC - All Rights Reserved